VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2017. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $10,225,000 | -17.2% | 713,550 | 0.0% | 2.16% | +21.8% |
| Q2 2017 | $12,344,000 | +56.8% | 713,550 | 0.0% | 1.77% | +63.8% |
| Q1 2017 | $7,870,000 | -24.0% | 713,550 | 0.0% | 1.08% | -43.0% |
| Q4 2016 | $10,361,000 | -60.3% | 713,550 | -32.9% | 1.90% | -60.2% |
| Q3 2016 | $26,098,000 | +21.9% | 1,063,057 | 0.0% | 4.76% | +63.6% |
| Q2 2016 | $21,410,000 | -23.5% | 1,063,057 | -0.1% | 2.91% | +4.2% |
| Q1 2016 | $27,974,000 | -59.4% | 1,063,657 | +56.9% | 2.79% | -41.9% |
| Q4 2015 | $68,919,000 | +85.8% | 678,000 | +226.0% | 4.81% | +83.4% |
| Q3 2015 | $37,103,000 | +14.9% | 208,000 | +43.1% | 2.62% | +43.5% |
| Q2 2015 | $32,280,000 | +485.2% | 145,306 | +423.2% | 1.83% | +438.9% |
| Q1 2015 | $5,516,000 | -63.4% | 27,770 | -73.6% | 0.34% | -57.7% |
| Q4 2014 | $15,051,000 | +465.6% | 105,172 | +418.5% | 0.80% | +464.1% |
| Q3 2014 | $2,661,000 | -92.9% | 20,284 | -93.1% | 0.14% | -93.9% |
| Q2 2014 | $37,239,000 | +1100.5% | 295,267 | +1154.9% | 2.33% | +704.5% |
| Q1 2014 | $3,102,000 | -35.9% | 23,529 | -42.9% | 0.29% | -18.8% |
| Q4 2013 | $4,838,000 | – | 41,209 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |